As of 2025-10-22, the Intrinsic Value of Sana Biotechnology Inc (SANA) is -5.12 USD. This SANA valuation is based on the model Peter Lynch Fair Value. With the current market price of 5.71 USD, the upside of Sana Biotechnology Inc is -189.63%.
Based on its market price of 5.71 USD and our intrinsic valuation, Sana Biotechnology Inc (SANA) is overvalued by 189.63%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -5.12 - -5.12 | -5.12 | -189.63% |
| DDM - Stable | (6.59) - (23.62) | (15.11) | -364.5% |
| DDM - Multi | (6.08) - (17.81) | (9.17) | -260.5% |
| Market Cap (mil) | 1,406.72 |
| Beta | 0.48 |
| Outstanding shares (mil) | 246.36 |
| Enterprise Value (mil) | 1,406.72 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.39% |
| Cost of Debt | 5.00% |
| WACC | 7.53% |